Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study

NCT01118585 is registered in ClinicalTrials.gov with EndoGastric Solutions as lead sponsor.

NCT NCT01118585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01118585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Lead sponsor
EndoGastric Solutions
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2010
Completion date
December 31, 2018
Enrollment
278 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease, hiatal hernia